Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Capri Holdings
CPRI
$1.88B
| $984M | 0.96% |
12,115,718
+861,963
| +8% | +$68M |
|
|
NVO
27
Novo Nordisk
NVO
$223B
| $964M | 0.95% |
52,194,040
-4,364,870
| -8% | -$76.1M |
|
|
WFM
28
DELISTED
Whole Foods Market Inc
WFM
| $962M | 0.94% |
16,633,830
-3,385,268
| -17% | -$201M |
|
29
SLB Ltd
SLB
$70.3B
| $957M | 0.94% |
10,615,386
+2,993,257
| +39% | +$270M |
|
|
RHT
30
DELISTED
Red Hat Inc
RHT
| $943M | 0.92% |
16,821,347
-513,207
| -3% | -$23.8M |
|
31
Illumina
ILMN
$28.2B
| $940M | 0.92% |
8,737,029
-640,742
| -7% | -$58.7M |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $931M | 0.91% |
11,014,910
+2,934,678
| +36% | +$232M |
|
33
Canadian Pacific Kansas City
CP
$83.2B
| $917M | 0.9% |
30,284,345
+4,674,920
| +18% | +$135M |
|
|
ESRX
34
DELISTED
Express Scripts Holding Company
ESRX
| $895M | 0.88% |
12,739,004
-1,141,689
| -8% | -$74.6M |
|
35
EOG Resources
EOG
$74.5B
| $879M | 0.86% |
10,470,944
-595,578
| -5% | -$51M |
|
36
Estee Lauder
EL
$29.7B
| $843M | 0.83% |
11,190,096
-2,088,003
| -16% | -$151M |
|
37
RTX Corp
RTX
$261B
| $841M | 0.83% |
11,745,446
-405,416
| -3% | -$27.6M |
|
38
Starbucks
SBUX
$120B
| $809M | 0.79% |
20,639,114
-746,572
| -3% | -$29.5M |
|
|
VMW
39
DELISTED
VMware, Inc
VMW
| $806M | 0.79% |
8,989,100
-282,219
| -3% | -$23.3M |
|
|
40
Adobe
ADBE
$94.3B
| $767M | 0.75% |
12,800,899
+8,831,623
| +222% | +$488M |
|
41
Abbott
ABT
$175B
| $727M | 0.71% |
18,959,761
+1,186,394
| +7% | +$43.7M |
|
42
Warner Bros
WBD
$67.4B
| $714M | 0.7% |
15,463,365
+1,552,941
| +11% | +$67.2M |
|
43
Union Pacific
UNP
$179B
| $705M | 0.69% |
8,394,524
-3,191,472
| -28% | -$253M |
|
44
Netflix
NFLX
$290B
| $673M | 0.66% |
127,990,940
+22,530,690
| +21% | +$111M |
|
45
BioMarin Pharmaceuticals
BMRN
$11.5B
| $660M | 0.65% |
9,396,076
+519,719
| +6% | +$35.3M |
|
|
DNKN
46
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $616M | 0.6% |
12,786,835
-985,004
| -7% | -$46.7M |
|
|
SPLK
47
DELISTED
Splunk Inc
SPLK
| $608M | 0.6% |
8,859,649
-506,210
| -5% | -$32.8M |
|
|
48
Merck
MRK
$315B
| $607M | 0.6% |
12,711,377
+9,691,237
| +321% | +$443M |
|
|
49
Morgan Stanley
MS
$339B
| $604M | 0.59% |
19,270,418
-13,483,975
| -41% | -$401M |
|
50
American Tower
AMT
$79.2B
| $536M | 0.53% |
6,709,183
+403,220
| +6% | +$31.3M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.